INTERIM CLINICAL UPDATE OF THE PHASE 1B TRIAL OF ATRC-101 AS MONOTHERAPY OR IN COMBINATION WITH PEMBROLIZUMAB FOR SELECT ADVANCED SOLID TUMORS

Authors
Category Primary study
JournalJOURNAL FOR IMMUNOTHERAPY OF CANCER
Year 2022
This article has no abstract
Epistemonikos ID: 861fbecf676fb9bdcbec1b5be7059ef1aaa8a079
First added on: Feb 15, 2025